semaglutide essence trial 2.4 mg in Participants With Metabolic Dysfunction‐Associated Steatohepatitis: Baseline Characteristics and Design of the Phase 3 Cell_Metabolism @KeystoneSymp The ESSENCE trial,

GLP-1 Insight 10 The impact scores for certain products like alcoholic beverages and sugary drinks show a drop in demand

The first usually means you need to adjust your normal medication, while the second raises concerns for pancreatitis , which needs immediate evaluation beyond regular lab tests

Its much simpler and you have the Porsche of peptides experience

All of the dynamics around GLP-1s, compounding shortage workarounds, and potential for DTC telehealth fallout I described last August seem to be playing out in 2025

While most food companies do not explicitly mention GLP-1s impact on their sales, snack-focused leaders are currently facing strong headwinds, with many announcing layoffs and restructuring